C07F 9/65517
Condensed with carbocyclic rings or carbocyclic ring systems
Official title: {condensed with carbocyclic rings or carbocyclic ring systems}
C07F9/65517 (Condensed with carbocyclic rings or carbocyclic ring systems) appears on 288 US grants and 261 published applications in this corpus.
Search patents in C07F- Granted patents
- 288
- Published applications
- 261
- Assignees
- 159
- Inventors
- 892
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 8 | 0 |
| 1996 | 7 | 0 |
| 1997 | 7 | 0 |
| 1998 | 17 | 0 |
| 1999 | 6 | 0 |
| 2000 | 8 | 0 |
| 2001 | 4 | 1 |
| 2002 | 9 | 5 |
| 2003 | 5 | 2 |
| 2004 | 1 | 18 |
| 2005 | 5 | 11 |
| 2006 | 10 | 14 |
| 2007 | 7 | 10 |
| 2008 | 6 | 18 |
| 2009 | 9 | 20 |
| 2010 | 9 | 10 |
| 2011 | 8 | 13 |
| 2012 | 15 | 17 |
| 2013 | 16 | 9 |
| 2014 | 12 | 11 |
| 2015 | 10 | 8 |
| 2016 | 9 | 14 |
| 2017 | 1 | 10 |
| 2018 | 10 | 13 |
| 2019 | 9 | 10 |
| 2020 | 10 | 16 |
| 2021 | 9 | 3 |
| 2022 | 7 | 8 |
| 2023 | 6 | 3 |
| 2024 | 3 | 4 |
| 2025 | 6 | 9 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Light-emitting device and electronic apparatus including the same22 Sep 2026US 12,745,559 B2Samsung Display Co., Ltd.
- Electron injection layer for an organic light-emitting diode (OLED)24 Feb 2026US 12,563,963 B2Novaled GmbH
- Condensed cyclic compound and organic electroluminescence device including the same27 Jan 2026US 12,538,702 B2Samsung Display Co., Ltd.
- Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy23 Dec 2025US 12,503,479 B2Cellectar Biosciences, Inc.
- Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy16 Dec 2025US 12,496,346 B2Cellectar Biosciences, Inc.
- Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same3 Sep 2026US 2026/0257213 A1LG Chem.Ltd.
- Prodrugs of mdma, mda, and derivatives thereof6 Aug 2026US 2026/0226017 A1EmpathBio, Inc.
- Modulator for promoting binding of butyrophilin 3a1/2a123 Jul 2026US 2026/0207637 A1Unicet Biotech Co. LLC.
- Hydroxyaminophosphinic acid derivatives14 May 2026US 2026/0132157 A1Merck Patent GmbH
- Agents and methods for treating dysproliferative diseases27 Nov 2025US 2025/0361218 A1Memorial Sloan Kettering Cancer Center
Most cited
By later US patents
- Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof152US 5,985,856 AUniversity of Kansas · 1999
- Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase117US 6,489,476 B1Metabasis Therapeutics, Inc. · 2002
- Amino acid derivatives, the process for their preparation and their applications to therapy85US 5,599,951 ASociete Civile Bioprojet · 1997
- Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof78US 7,476,399 B2Senomyx, Inc. · 2009
- .alpha.-phosphonosulfonate squalene synthetase inhibitors77US 5,712,396 A1998